Smith & Nephew (NYSE: SNN)
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-23 | ||||||
REV |
FY 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.810 | ||||||
REV | 5.212B |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Smith & Nephew (NYSE: SNN) through any online brokerage.
Other companies in Smith & Nephew’s space includes: Steris (NYSE:STE), Masimo (NASDAQ:MASI), Envista Holdings (NYSE:NVST), Koninklijke Philips (NYSE:PHG) and Abbott Laboratories (NYSE:ABT).
The latest price target for Smith & Nephew (NYSE: SNN) was reported by Redburn Partners on Friday, March 4, 2022. The analyst firm set a price target for 0.00 expecting SNN to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Smith & Nephew (NYSE: SNN) is $26.165 last updated August 9, 2022, 7:59 PM UTC.
A quarterly cash dividend of $0.45 per share of Class A Common Stock. The quarterly cash dividend was payable on May 11, 2022 to stockholders of record on March 31, 2022.
Smith & Nephew’s H1 earnings are confirmed for Tuesday, August 23, 2022.
There is no upcoming split for Smith & Nephew.
Smith & Nephew is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.